富国中证医药50ETF联接C(012802)财务指标
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 本期已实现收益 |
-4,429,502.68 |
-20,405,837.51 |
-8,398,522.41 |
7,872,974.26 |
| 本期利润 |
1,995,240.16 |
-11,347,087.87 |
-16,507,850.00 |
-11,188,753.35 |
| 加权平均基金份额本期利润 |
0.02 |
-0.11 |
-0.16 |
-0.11 |
| 本期加权平均净值利润率(%) |
3.31 |
-15.79 |
-21.54 |
-12.71 |
| 本期基金份额净值增长率(%) |
3.13 |
-11.25 |
-18.74 |
-9.75 |
| 期末可供分配利润 |
-18,928,410.57 |
-23,713,562.79 |
-34,580,809.72 |
-20,371,843.19 |
| 期末可供分配基金份额利润 |
-0.25 |
-0.27 |
-0.33 |
-0.18 |
| 期末基金资产净值 |
57,236,191.83 |
63,700,812.64 |
69,336,888.76 |
93,501,050.58 |
| 期末基金份额净值 |
0.75 |
0.73 |
0.67 |
0.82 |
| 基金份额累计净值增长率(%) |
-24.85 |
-27.13 |
-33.28 |
-17.89 |
微信公众号
证券之星APP
基本资料
